Literature DB >> 12077389

Neurodegeneration. A glutamine-rich trail leads to transcription factors.

Richard N Freiman1, Robert Tjian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077389     DOI: 10.1126/science.1073845

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  28 in total

1.  Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.

Authors:  Haiqun Jia; Judit Pallos; Vincent Jacques; Alice Lau; Bin Tang; Andrew Cooper; Adeela Syed; Judith Purcell; Yi Chen; Shefali Sharma; Gavin R Sangrey; Shayna B Darnell; Heather Plasterer; Ghazaleh Sadri-Vakili; Joel M Gottesfeld; Leslie M Thompson; James R Rusche; J Lawrence Marsh; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

2.  Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.

Authors:  Jonathan A Sayer; Maria Manczak; Lakshmi Akileswaran; P Hemachandra Reddy; Vincent M Coghlan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Mass spectrometric identification of novel lysine acetylation sites in huntingtin.

Authors:  Xin Cong; Jason M Held; Francesco DeGiacomo; Akilah Bonner; Jan Marie Chen; Birgit Schilling; Gregg A Czerwieniec; Bradford W Gibson; Lisa M Ellerby
Journal:  Mol Cell Proteomics       Date:  2011-06-18       Impact factor: 5.911

4.  Aggregation kinetics of interrupted polyglutamine peptides.

Authors:  Robert H Walters; Regina M Murphy
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

5.  High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.

Authors:  Seth A Ament; Jocelynn R Pearl; Andrea Grindeland; Jason St Claire; John C Earls; Marina Kovalenko; Tammy Gillis; Jayalakshmi Mysore; James F Gusella; Jong-Min Lee; Seung Kwak; David Howland; Min Young Lee; David Baxter; Kelsey Scherler; Kai Wang; Donald Geman; Jeffrey B Carroll; Marcy E MacDonald; George Carlson; Vanessa C Wheeler; Nathan D Price; Leroy E Hood
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

6.  Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia.

Authors:  W Sako; R Morigaki; R Kaji; I Tooyama; S Okita; K Kitazato; S Nagahiro; A M Graybiel; S Goto
Journal:  Neuroscience       Date:  2011-05-19       Impact factor: 3.590

7.  Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Authors:  Zsolt Keresztessy; Eva Csosz; Jolán Hársfalvi; Krisztián Csomós; Joe Gray; Robert N Lightowlers; Jeremy H Lakey; Zoltán Balajthy; László Fésüs
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

8.  The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.

Authors:  Elizabeth A Thomas; Giovanni Coppola; Paula A Desplats; Bin Tang; Elisabetta Soragni; Ryan Burnett; Fuying Gao; Kelsey M Fitzgerald; Jenna F Borok; David Herman; Daniel H Geschwind; Joel M Gottesfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

9.  A glutamine-rich factor affects stem cell genesis in leech.

Authors:  Kristi A Hohenstein; Shirley A Lang; Tej Nuthulaganti; Daniel H Shain
Journal:  Stem Cells Int       Date:  2010-01-01       Impact factor: 5.443

10.  Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation.

Authors:  Robert H Walters; Regina M Murphy
Journal:  J Mol Biol       Date:  2009-08-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.